The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 20,001–20,100 of 31,469
Rushing, K. A., Bolyard, M. L., Kelty, T. J., Wieschhaus, N., Pavela, G., Rector, R. S., & Plaisance, E. P. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1165224 · Cited by 11
Wang, X., Hao, W., Huang, X., & Duan, Z. (2023) · Food & Function · doi:10.1039/d2fo03206f · Cited by 12
Lailerd, M., Linn, T. W., Lailerd, N., Amornlerdpison, D., & Imsumran, A. (2023) · Applied Sciences · doi:10.3390/app13116454 · Cited by 11
Lee, Y. K., Koo, B. K., Joo, S. K., Lee, D. H., Jang, H., Chai, J. W., Lee, M. S., Jang, S. W., So, Y. H., Park, J. H., et al. (2023) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17601 · Cited by 11
Aira, T., Kokko, S. P., Heinonen, O. J., Korpelainen, R., Kotkajuuri, J., Parkkari, J. P., Savonen, K. P., Toivo, K., Uusitalo, A. L. T., Valtonen, M., et al. (2023) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.14415 · Cited by 16
Sheu, A., Blank, R. D., Tran, T. S., et al. (2023) · JBMR Plus · doi:10.1002/jbm4.10780 · Cited by 11
Aronica, L., Landry, M. J., Rigdon, J., & Gardner, C. D. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1220020 · Cited by 12
Gupta, Y., Goyal, A., Ambekar, S., Kalaivani, M., Bhatla, N., & Tandon, N. (2023) · Journal of Diabetes · doi:10.1111/1753-0407.13461 · Cited by 12
Lehtovirta, M., Pahkala, K., Rovio, S., Magnussen, C. G., Laitinen, T. T., Niinikoski, H., Lagström, H., Viikari, J. S. A., Rönnemaa, T., Jula, A., et al. (2023) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwad285 · Cited by 11
Body mass index is a good predictor of metabolic abnormalities in polycystic ovary syndrome
Fruzzetti, F., Fidecicchi, T., Benelli, E., Baldari, F., & Tonacchera, M. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02210-4 · Cited by 11
Zhou, Z., Ju, H., Sun, M., Chen, H., Ji, H., Jiang, D., Ji, Y., & Ji, J. (2015) · Endocrine Journal · doi:10.1507/endocrj.ej15-0152 · Cited by 11
Sasai, H., Matsuo, T., Fujita, M., Saito, M., & Tanaka, K. (2010) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/j.1447-0594.2010.00630.x · Cited by 11
Yates, T. E., Davies, M. J., Henson, J. J., Edwardson, C. L., Webb, D. R., Bodicoat, D. H., Webb, M. A., Howard, P., Cooper, J. A., Humphries, S. E., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124062 · Cited by 11
Dobe, M., Geisler, A., Hoffmann, D., Kleber, M., von Köding, P., Lass, N., Müther, S., Pohl, B., Rose, K., Schaefer, A., et al. (2011) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-011-1261-x · Cited by 11
Urinary albumin excretion within the normal range predicts the development of diabetes in Korean men
Park, S. K., Seo, M. H., Ryoo, J., Kim, M., Choi, J., Shin, H., Choi, Y., & Hong, H. P. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.05.006 · Cited by 11
Suárez‐Ortegón, M. F., Arbeláez, A., Mosquera, M., et al. (2015) · Archives of Medical Research · doi:10.1016/j.arcmed.2015.07.007 · Cited by 11
Body fat distribution and its associated factors in Korean women with polycystic ovary syndrome
Jin, C. H., Yuk, J., Choi, K. M., Yi, K. W., Kim, T., Hur, J. Y., & Shin, J. (2015) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.12767 · Cited by 11
Verduci, E., Radaelli, G., Salvioni, M., Riva, E., & Giovannini, M. (2010) · Acta Paediatrica · doi:10.1111/j.1651-2227.2010.02120.x · Cited by 11
Satirapoj, B., Supasyndh, O., Phantana-Angkul, P., et al. (2011) · PubMed · Cited by 11
Kurata, M., Tsuboi, A., Takeuchi, M., Fukuo, K., & Kazumi, T. (2015) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2015.0085 · Cited by 11
Jing, C., Xu, S., Ming, J., Cai, J., Zhang, R., Shen, H., Yang, W., & Ji, Q. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.07.013 · Cited by 11
Hussein, A. M., Omar, N. M., Sakr, H. F., Elsamanoudy, A. Z., & Shaheen, D. (2011) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y11-012 · Cited by 11
Wang, H., & Jun-lu, B. A. O. (2012) · 中医杂志：英文版 · doi:10.1016/s0254-6272(12)60032-6 · Cited by 11
Eissa, L. A., Abdel‐Rahman, N., & Eraky, S. M. (2015) · Egyptian Journal of Basic and Applied Sciences · doi:10.1016/j.ejbas.2015.01.002 · Cited by 11
Insulin Resistance and Blood Pressure Circadian Variation in an Obese Hypertensive Population
Diamantopoulos, E. J., Andreadis, E. A., Tsourous, G. I., et al. (2006) · Clinical and Experimental Hypertension · doi:10.1080/10641960600946106 · Cited by 11
Carlsen, S. M., Grill, V., & Følling, I. (1998) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(97)00121-6 · Cited by 11
Khan, B. V. (2011) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944711420464 · Cited by 11
Assessment of insulin resistance using surrogate markers in patients of metabolic syndrome
Bhatnagar, M. K., Arora, S., Singh, V., & Bhattacharjee, J. (2010) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2010.07.009 · Cited by 10
García-García, M. R., Morales-Lanuza, M. A., Campos-Perez, W. Y., et al. (2014) · Lifestyle Genomics · doi:10.1159/000371801 · Cited by 11
Prior, S. J., Jenkins, N. T., Brandauer, J., Weiss, E. P., & Hagberg, J. M. (2011) · Metabolism · doi:10.1016/j.metabol.2011.07.003 · Cited by 11
Kürşat, S., Çolak, H., Toraman, A., et al. (2010) · Scandinavian Journal of Urology and Nephrology · doi:10.3109/00365591003733682 · Cited by 11
Gu, P., Jiang, W., Du, H., et al. (2010) · Journal of Endocrinological Investigation · doi:10.1007/bf03346629 · Cited by 11
Wei, J., TANG, Q., Liu, L., & BIN, J. (2013) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2013.891 · Cited by 11
Doneda, D., Lopes, A. L., Teixeira, B. C., et al. (2014) · Clinical Nutrition · doi:10.1016/j.clnu.2014.08.010 · Cited by 11
Niakaris, K., Magkos, F., Geladas, N. D., & Sidossis, L. S. (2005) · Journal of Sports Sciences · doi:10.1080/02640410400023241 · Cited by 11
Guo, A., Daniels, N. A., Thuma, J. R., McCall, K. D., Malgor, R., & Schwartz, F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117556 · Cited by 11
Zhang, L., Li, L., Yang, M., Liu, H., & Yang, G. (2011) · Cytokine · doi:10.1016/j.cyto.2011.07.003 · Cited by 11
Siviero‐Miachon, A. A., Monteiro, C. M. D. C., Pires, L. V., Rozalem, A. C., da Silva, N. S., Petrilli, A. S., & Spinola‐Castro, A. M. (2011) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302011000800022 · Cited by 11
Ueno, M., Fujita, K., Yamamoto, H., Ikeda, T., Suga, T., Yamaji, K., Ikuta, S., Kobuke, K., Iwanaga, Y., Angiolillo, D. J., et al. (2015) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-015-1177-7 · Cited by 11
Morcillo, S., Rojo‐Martínez, G., Martín‐Núñez, G. M., et al. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.090637 · Cited by 11
Oginö, K., Kato, M., Furuse, Y., Kinugasa, Y., Kaetsu, Y., Mizuta, E., Sugihara, S., Ishida, K., Yanagihara, K., Hisatome, I., et al. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-0395 · Cited by 12
Beneficial effects of co-enzyme Q10 and rosiglitazone in fructose-induced metabolic syndrome in rats
Mansour, S. M., Zaki, H. F., & El-Denshary, E.-E.-D. S. (2012) · Bulletin of Faculty of Pharmacy Cairo University · doi:10.1016/j.bfopcu.2012.10.001 · Cited by 11
Jeong, S. J., Kim, C. O., Song, Y. G., Baek, J. H., Kim, S. B., Jin, S. J., Ku, N. S., Han, S. H., Choi, J. Y., Lee, H. C., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.08.003 · Cited by 11
Lim, S. K., Hong, J., Liu, C., Hivert, M., White, C. C., Murabito, J. M., O’Donnell, C. J., Dupuis, J., Florez, J. C., & Meigs, J. B. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.03.037 · Cited by 11
Adolescent and adult African Americans have similar metabolic dyslipidemia
Gidding, S. S., Keith, S. W., & Falkner, B. E. (2014) · Journal of clinical lipidology · doi:10.1016/j.jacl.2014.11.010 · Cited by 11
Yoon, C.-Y., Lee, M. J., Kee, Y. K., Lee, E., Joo, Y. S., Han, I. M., Han, S. G., Oh, H. J., Park, J. T., Han, S. H., et al. (2014) · Kidney Research and Clinical Practice · doi:10.1016/j.krcp.2014.10.002 · Cited by 11
Anti-diabetic Effects of Fermented Green Tea in KK-AyDiabetic Mice
Lee, S., Park, S.-L., Nam, Y., Yi, S.-H., & Lim, S. (2013) · Korean Journal of Food Science and Technology · doi:10.9721/kjfst.2013.45.4.488 · Cited by 11
Moreira, A. P. B., Alves, R. D. M., Teixeira, T. F. S., Macedo, V. S., de Oliveira, L. L., Costa, N. M. B., Bressan, J., Pelúzio, M. D. C. G., Mattes, R. D., & Alfenas, R. D. C. G. (2014) · European Journal of Nutrition · doi:10.1007/s00394-014-0817-6 · Cited by 12
The STRIP Study: Long-Term Impact of a Low Saturated Fat/Low Cholesterol Diet
Niinikoski, H., Pahkala, K., Viikari, J. S. A., et al. (2014) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-014-0410-9 · Cited by 11
Studying progression from glucose intolerance to type 2 diabetes in obese children
Dubinina, I. A., Chistiakov, D. A., Eremina, I. A., Бровкин, А. Н., Zilberman, L. I., Nikitin, A. G., Кураева, Т. Л., Nosikov, V. V., Peterkova, V. A., & Dedov, I. I. (2014) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2014.07.002 · Cited by 11
Tubić, B., Magnusson, P., Swolin‐Eide, D., et al. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.42 · Cited by 11
von Willebrand Factor Antagonizes Nitric Oxide Synthase To Promote Insulin Resistance during Hypoxia
Singh, B., Biswas, I., Garg, I., Sugadev, R., Singh, A. K., Dey, S., & Khan, G. A. (2013) · Biochemistry · doi:10.1021/bi401061e · Cited by 11
Kanno, H., Kiyama, T., Fujita, I., et al. (2009) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607109333003 · Cited by 11
Gümüş, Ü., Güzel, A. İ., Topçu, H. O., Tımur, H., Yılmaz, N., & Danışman, N. (2014) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2014.08.007 · Cited by 11
Benedini, S., Caimi, A., Alberti, G., et al. (2010) · Sport Sciences for Health · doi:10.1007/s11332-010-0094-6 · Cited by 11
Fang, F. S., Cheng, X. L., Gong, Y., Wang, L. C., Li, C., Li, J., Tian, H., & Li, C. L. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.918030 · Cited by 11
Impact of PTBP1 rs11085226 on glucose-stimulated insulin release in adult Danes
Hansen, T. H., Vestergaard, H., Jørgensen, M. E., Jørgensen, M. E., Lauritzen, T., Brandslund, I., Christensen, C., Pedersen, O. B., Hansen, T., & Gjesing, A. P. (2015) · BMC Medical Genetics · doi:10.1186/s12881-015-0160-7 · Cited by 11
Liu, Z., Hu, Y., Yang, X., Tan, A., Gao, Y., Qin, X. Y., Liang, Y., Mo, Z., & Peng, T. (2012) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2012.08.022 · Cited by 11
Cedó, L., Castell‐Auví, A., Pallarès, V., Blay, M., Ardèvol, A., & Pinent, M. (2013) · International Journal of Food Science · doi:10.1155/2013/875314 · Cited by 11
Sun, Y. S., Wang, C., Yang, W., Wang, Y., Zhang, X., Ma, Z., Song, J., Lin, P., Liang, K., Ma, A., et al. (2014) · International Urology and Nephrology · doi:10.1007/s11255-014-0880-1 · Cited by 11
Uchida, J., Iwai, T., Kabei, K., et al. (2014) · Transplantation Proceedings · doi:10.1016/j.transproceed.2013.11.146 · Cited by 11
Çağlar, G. S., Ozdemir, E. D., Kiseli, M., et al. (2014) · Gynecologic and Obstetric Investigation · doi:10.1159/000358826 · Cited by 11
Replication of calpain-10 genetic association with carotid intima-media thickness
Goodarzi, M. O., Taylor, K. D., Jones, M. R., et al. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.12.038 · Cited by 11
Giordano, U., Corte, C. D., Cafiero, G., Liccardo, D., Turchetta, A., Hoshemand, K., Fintini, D., Bedogni, G., Matteucci, M. C., & Nobili, V. (2014) · European Journal of Pediatrics · doi:10.1007/s00431-014-2342-2 · Cited by 11
Cicero, A. F. G., Sando, V. D., Benedetto, D., Cevenini, M., Grandi, E., & Borghi, C. (2012) · Nutrafoods · doi:10.1007/s13749-012-0018-y · Cited by 11
Role of Impaired Glucose Metabolism in the Postherpetic Neuralgia
Bosco, D., Plastino, M., Bartolo, M. D., Cristiano, D., Ettore, M., Zurlo, G., Bosco, F., Colica, C., Tallarigo, F., & Fava, A. (2013) · Clinical Journal of Pain · doi:10.1097/ajp.0b013e318274b2ed · Cited by 11
Miranda, M., Escoté, X., Alcaide, M. J., Solano, E., Ceperuelo‐Mallafré, V., Hernández, P., Wabitsch, M., & Vendrell, J. J. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00699.2009 · Cited by 11
Serum Cystatin C in Relation to Fat Mass Loss After Bariatric Surgery"
Śledziński, T., Proczko‐Markuszewska, M., Kaska, Ł., et al. (2012) · Polish Journal of Surgery · doi:10.2478/v10035-012-0033-0 · Cited by 11
Resistencia insulínica y artritis reumatoide
Ferraz‐Amaro, I., Díaz‐González, F., Juanatey, C. G., & González-Gay, M. Á. (2010) · Reumatología Clínica · doi:10.1016/j.reuma.2010.03.010 · Cited by 11
Tinahones, F. J., Queipo‐Ortuño, M. I., Clemente‐Postigo, M., Fernández‐García, D., Mingrone, G., & Cardona, F. (2011) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2011.08.022 · Cited by 11
Ybarra, J., Pou, J. M., Planas, F., Ballesta‐López, C., Echevarne, F., Romeo, J. H., & Navarro‐López, F. (2007) · Endocrine Practice · doi:10.4158/ep.13.6.590 · Cited by 11
Mohammadi, S., Hosseinzadeh‐Attar, M. J., Hossein‐Nezhad, A., Hosseini, S. H., Eshraghian, M. R., Nezhad, M. K., Rahmani, M., & Karimi, M. (2011) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2012.02.014 · Cited by 11
Sayers, S. M., Mackerras, D., Singh, G. R., et al. (2004) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2003.12.006 · Cited by 11
Latha, R., Shanthi, P., & Sachdanandam, P. (2013) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2012-0443 · Cited by 11
Detection of small bowel tumors by videocapsule endoscopy in patients with acromegaly
Ronchi, C. L., Coletti, F., Fesce, E., et al. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03346495 · Cited by 11
Yoshinaga, M., Takahashi, H., Shinomiya, M., Miyazaki, A., Kuribayashi, N., & Ichida, F. (2010) · Journal of atherosclerosis and thrombosis · doi:10.5551/jat.5264 · Cited by 13
Lee, Y., Kown, M. H., Kim, K. J., Lee, E. Y., Kim, D., Lee, B., Kang, E. S., Soo, B., & Lee, H. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108772 · Cited by 11
Sullivan, T. J., Dairaghi, D. J., Krasinski, A., Miao, Z., Wang, Y., Zhao, B. N., Baumgart, T., Berahovich, R., Ertl, L. S., Pennell, A. M. K., et al. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.190918 · Cited by 11
RetractedRył, A., Rotter, I., Słojewski, M., Jędrzychowska, A., Marcinowska, Z., Grabowska, M., & Laszczyńska, M. (2015) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph120303327 · Cited by 11
Kawamoto, R., Tabara, Y., Kohara, K., Miki, T., Ohtsuka, N., Kusunoki, T., Takayama, S., & Abe, M. (2011) · Endocrine Research · doi:10.3109/07435800.2010.534756 · Cited by 11
Khoo, E. Y.-H., Stevenson, M. C., Leverton, E., Cross, R., Eriksson, J. W., Poucher, S. M., Spendlove, I., Morris, P. G., Macdonald, I. A., Mansell, P., et al. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2219-z · Cited by 11
Common genetic variation in sFRP5 is associated with fat distribution in men
Camp, J. K. V., Beckers, S., Zegers, D., Verrijken, A., Gaal, L. F. V., & Hul, W. V. (2013) · Endocrine · doi:10.1007/s12020-013-0088-7 · Cited by 11
Aller, R., de Luis, D. A., Pacheco, D., et al. (2013) · PubMed · doi:10.3305/nh.2012.27.5.6011 · Cited by 11
Effect of antiobesity medications in patients with type 2 diabetes mellitus
Choussein, S., Makri, A., Frangos, C. C., Petridou, E. T., & Daskalopoulou, S. S. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.01026.x · Cited by 11
Wolff, E., Vergnes, M., Portugal, H., Defoort, C., Amiot, M. J., Lairon, D., & Nicolay, A. (2011) · Journal of Nutrition · doi:10.3945/jn.111.141333 · Cited by 14
Solovjova, S., Ryliškytė, L., Čelutkienė, J., et al. (2015) · Blood Pressure · doi:10.3109/08037051.2016.1093334 · Cited by 11
Tanrıkulu-Küçük, S., Koçak, H., Öner-İyidoğan, Y., Seyithanoğlu, M., Topparmak, E., & Tapan, T. K. (2015) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2015.1010177 · Cited by 11
Desiderio, J., Trastulli, S., Scalercio, V., Cirocchi, R., Carloni, G., Moriconi, E., Boselli, C., Noya, G., & Amilcare, P. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0308 · Cited by 11
Increased circulating urocortin-3 levels is associated with polycystic ovary syndrome
Temür, M., Yılmaz, Ö., Aksun, S., Özbay, P. Ö., Çalan, M., Küme, T., Karakulak, M., & Korkmaz, H. A. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1110135 · Cited by 11
Seo, J. Y., Kim, M. K., Choi, B. Y., Kim, Y., Cho, S., & Shin, J. (2014) · Journal of Korean Medical Science · doi:10.3346/jkms.2014.29.7.941 · Cited by 11
Martins, C., do Nascimento, M. M., Pecoits‐Filho, R., Leinig, C. E., Gonçalves, L. F. S., Fuerbringer, R., Stenvinkel, P., Lindholm, B., & RIELLA, M. C. (2007) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2006.07.004 · Cited by 11
Detecting Insulin Resistance in Pakistani Subjects by Fasting Blood Samples
Hydrie, M. Z. I. (2012) · The Open Diabetes Journal · doi:10.2174/1876524601205010020 · Cited by 11
Seow, K., Lin, Y., Hwang, J., Wang, P.-Y., Ho, L. ‐., Lin, Y., & Juan, C. (2010) · Human Reproduction · doi:10.1093/humrep/deq351 · Cited by 11
Klein, O. L., Okwuosa, T. M., Chan, C., Schreiner, P. J., Kanaya, A. M., Liu, K., & Green, D. (2013) · Diabetic Medicine · doi:10.1111/dme.12387 · Cited by 11
Artery calcification, osteoporosis, and plasma adiponectin levels in Chinese elderly
Zhan, J., Wáng, Y., He, J., Wang, Y., Tan, P., Tang, Z.-Y., Deng, H., Huang, W., & Liu, Y. (2015) · Heart & Lung · doi:10.1016/j.hrtlng.2015.08.006 · Cited by 11
Cardoso-Sánchez, L. I., Gómez-Díaz, R. A., & Wacher, N. H. (2015) · Nutrition Research · doi:10.1016/j.nutres.2015.05.019 · Cited by 11
de Luis, D. A., Aller, R., Izaola, O., et al. (2012) · PubMed · Cited by 11
Yoon, Y. S., Choi, H. S., Kim, J. K., Kim, Y. I., & Oh, S. W. (2015) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2015.11.001 · Cited by 10
Hashemipour, S., Esmailzadehha, N., Mohammadzadeh, M., & Ziaee, A. (2016) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-015-0250-8 · Cited by 11
Tabbaa, A., Shaker, M., López, R., Hoshemand, K., Nobili, V., & Alkhouri, N. (2015) · Pediatric Gastroenterology Hepatology & Nutrition · doi:10.5223/pghn.2015.18.3.168 · Cited by 11
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
